A multicenter, open-label, randomized comparative study of tigecycline vs ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infection.

Trial Profile

A multicenter, open-label, randomized comparative study of tigecycline vs ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2013

At a glance

  • Drugs Tigecycline (Primary) ; Ceftriaxone; Metronidazole
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 12 Sep 2009 Results were presented at ICAAC 2009.
    • 27 Jul 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 10 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top